Company Filing History:
1 out of 1 
1 out of 832,843 Years Active: 2011
Title: The Innovative Contributions of Louise Royle
Introduction
Louise Royle is a prominent inventor based in Oxon, GB. She has made significant contributions to the field of glycosylation markers, particularly in relation to physiological conditions and cancer diagnostics. With a total of 2 patents, her work has the potential to impact medical diagnostics and monitoring.
Latest Patents
Royle's latest patents include an automated strategy for identifying physiological glycosylation markers. This innovative approach allows for the identification and quantification of glycosylation markers associated with various physiological conditions, including diseases. Utilizing quantitative HPLC analysis, her method can analyze glycans released from unpurified glycoproteins, which can be either total glycoproteins or a selection thereof. The identified glycosylation markers can be native glycans or digestion products, and this strategy is compatible with high throughput formats and glycan database searching.
Another significant patent focuses on glycosylation markers for cancer diagnosing and monitoring. Similar to her previous work, this patent employs quantitative HPLC analysis to identify and quantify glycosylation markers specifically related to cancer. The identified markers can be used for diagnosing and monitoring cancer in subjects, as well as for identifying glycoprotein biomarkers that carry these markers.
Career Highlights
Throughout her career, Louise Royle has worked with notable organizations, including the National Institute for Bioprocessing Research and Training Limited (NIBRT). Her expertise in glycosylation and biomarker identification has positioned her as a key figure in her field.
Collaborations
Royle has collaborated with esteemed colleagues such as Raymond A. Dwek and Catherine M. Radcliffe. These collaborations have further enhanced her research and contributions to the scientific community.
Conclusion
Louise Royle's innovative work in identifying glycosylation markers has the potential to revolutionize the way physiological conditions and cancer are diagnosed and monitored. Her contributions are invaluable to the field of bioprocessing and medical diagnostics.